← Back to Patent Explorer
US4061753A Expired / Lapsed US ⏱️ 0.0 years remaining

Treating psoriasis with transient pro-drug forms of xanthine derivatives

Assignee: Interx Research Corp
•
Filing: 1976-02-06
•
Granted: 1977-12-06
•
Expires: 1996-02-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of the formula: ##STR1## wherein R, which may be the same or different, represents a member selected from the group consisting of --CH 3 , --C 2 H 5 , --C 3 H 7 , iso--C 3 H 7 , --C 4 H 9 , iso--C 4 H 9 , pentyl, benzyl, allyl, 2-hydroxyethyl, cyclohexyl, 2-isobutenyl, hydroxymethyl, 2-phenylethyl and -CH 2 O-R 2 , wherein R 2 is defined infra; wherein R 1 represents a member selected from the group consisting of H, C 1 -C 7 straight or branched alkyl, CCl 3 , CBr 3 , CI 3 , ##STR2## CH 3 O--CH 2 --, (CH 3 ) 2 NCH 2 --, ##STR3## wherein R 3 represents a member selected from the group consisting of -OH, halogen (Cl, Br, I), --OCH 3 , -COOCH 3 , -NO 2 and -OCOCH 3 ; wherein ##STR4## and wherein R 2 represents a member selected from the group consisting of ##STR5## wherein R 4 is a member selected from the group consisting of C 2 -C 20 straight or branched alkyl (C 3 -C 7 preferred), --[--(CH 2 ) m --], wherein m represents an integer of from 0 to 10, ##STR6## wherein R 3 is defined as above, ##STR7## the residue of any naturally occurring amino acid, the residue of any N- substituted amino acid, wherein said substituent is any amino acid protective group cleavable via hydrogenolysis or hydrolysis (e.g., formyl, benzyloxy, carbonyl, t-butyloxycarbonyl), the residue of an N,N-C 1 -C 5 -dialkyl or cycloalkylamino acid, ##STR8## wherein n represents an integer of from 1-5 and R 5 and R 6 which may be the same or different represent C 1 -C 5 alkyl or together form a heterocyclic ring with the N atom to which they are attached (e.g., pyrolidine, piperidine, morpholine, piperazine, imidazoline, thiazolidine, isoxazolidine), imidazolyl, O-C 1 -C 8 alkyl, O-benzyl, O-phenyl and ##STR9## wherein n, R 5 and R 6 are defined as above; and wherein R 2 further represents a member selected from the group consisting of straight or branched C 1 -C 20 alkyl, ##STR10## wherein n, R 5 and R 6 are defined as above, phenyl, tolyl, xylyl, and --SO 2 --R 7 , wherein R 7 is a straight or branched C 1 -C 20 alkyl useful in treating psoriasis in warm-blooded animals are provided.

Inventors

  • 👤 Nicolae S. Bodor
  • 👤 Kenneth B. Sloan

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 17:55
CPC Classifications
C; C07; C07D; C07D473/00; C07D473/02; C07D473/04; C07D473/06; C07D473/08; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55

Claims Analysis

Total Claims: 100
Claim 1
Independent Claim 372 words
A method for topically treating psoriasis on a warm-blooded animal afflicted with the same which comprises topically administering thereto an anti-psoriatic effective amount of a compound having the formula: ##STR247## wherein R, which may be the same or different, represents a member selected from the group consisting of --CH 3 , --C 2 H 5 , iso--C 3 H 7 , --C 4 H 9 , iso--C 4 H 9 , pentyl, benzyl, allyl, 2-hydroxyethyl, cyclohexyl, 2-isobutenyl, hydroxymethyl, 2-phenylethyl and --CH 2 O 13R 2 , wherein R 2 is defined infra; wherein R 1 represents a member selected from the group consisting of H, C 1 -C 7 straight or branched alky, CCl 3 , CBr 3 , CI 3 , ##STR248## CH 3 O--CH 2 --, (CH 3 ) 2 NCH 2 --, --CHO, ##STR249## wherein R 3 represents a member selected from the group consisting of --OH, halogen, --OCH 3 , --COOCH 3 , --NO 2 and --OCOCH 3 ; wherein X is ##STR250## and wherein R 2 represents a member selected from the group consisting of ##STR251## wherein R 4 is a member selected from the group consisting of C 2 -C 20 straight or branched alkyl, ##STR252## wherein R 3 is defined as above, ##STR253## the residue of any naturally occurring amino acid, the residue of any N-- substituted amino acid, wherein said substituent is any amino acid protective group cleavable via hydrogenolysis or hydrolysis the residue of an N,N--C 1 --C 5 --dialkyl or cycloalkylamino acid, ##STR254## wherein n represents an integer of from 1-5 and R 5 and R 6 which may be the same or different represent C 1 -C 5 alkyl or together form a heterocyclic ring with the N atom to which they are attached, imidazolyl, O--C 1 --C 8 alkyl, O-benzyl, O-phenyl and ##STR255## wherein n, R 5 and R 6 are defined as above; and wherein R 2 further represents a member selected from the group consisting of straight or branched C 1 -C 20 alkyl, ##STR256## wherein n, R 5 and R 6 are defined as above, phenyl, tolyl, xylyl, and --SO 2 --R 7 , wherein R 7 is a straight or branched C 1 -C 20 alkyl.
Claim 2
Independent Claim 372 words
A method for topically treating psoriasis on a warm-blooded animal afflicted with the same which comprises topically administering thereto an anti-psoriatic effective amount of a compound having the formula: ##STR247## wherein R, which may be the same or different, represents a member selected from the group consisting of --CH 3 , --C 2 H 5 , iso--C 3 H 7 , --C 4 H 9 , iso--C 4 H 9 , pentyl, benzyl, allyl, 2-hydroxyethyl, cyclohexyl, 2-isobutenyl, hydroxymethyl, 2-phenylethyl and --CH 2 O 13R 2 , wherein R 2 is defined infra; wherein R 1 represents a member selected from the group consisting of H, C 1 -C 7 straight or branched alky, CCl 3 , CBr 3 , CI 3 , ##STR248## CH 3 O--CH 2 --, (CH 3 ) 2 NCH 2 --, --CHO, ##STR249## wherein R 3 represents a member selected from the group consisting of --OH, halogen, --OCH 3 , --COOCH 3 , --NO 2 and --OCOCH 3 ; wherein X is ##STR250## and wherein R 2 represents a member selected from the group consisting of ##STR251## wherein R 4 is a member selected from the group consisting of C 2 -C 20 straight or branched alkyl, ##STR252## wherein R 3 is defined as above, ##STR253## the residue of any naturally occurring amino acid, the residue of any N-- substituted amino acid, wherein said substituent is any amino acid protective group cleavable via hydrogenolysis or hydrolysis the residue of an N,N--C 1 --C 5 --dialkyl or cycloalkylamino acid, ##STR254## wherein n represents an integer of from 1-5 and R 5 and R 6 which may be the same or different represent C 1 -C 5 alkyl or together form a heterocyclic ring with the N atom to which they are attached, imidazolyl, O--C 1 --C 8 alkyl, O-benzyl, O-phenyl and ##STR255## wherein n, R 5 and R 6 are defined as above; and wherein R 2 further represents a member selected from the group consisting of straight or branched C 1 -C 20 alkyl, ##STR256## wherein n, R 5 and R 6 are defined as above, phenyl, tolyl, xylyl, and --SO 2 --R 7 , wherein R 7 is a straight or branched C 1 -C 20 alkyl.
Claim 3
Dependent Claim 11 words
The method of claim 1 wherein said compound is: 7-Pivaloxymethyl theophylline.
Claim 4
Dependent Claim 12 words
The method of claim 1, wherein said compound is: 7-(Pyridinium chloride)methyl theophylline.
Claim 5
Dependent Claim 11 words
The method of claim 1, wherein said compound is: 7-Hexanoyloxymethyl theophylline.
Claim 6
Dependent Claim 11 words
The method of claim 1, wherein said compound is: 7-Octanoyloxymethyl theophylline.
Claim 7
Dependent Claim 11 words
The method of claim 1, wherein said compound is: 7-Butanoyloxymethyl theophylline.
Claim 8
Dependent Claim 11 words
The method of claim 1, wherein said compound is: 7-Ethoxycarbonoloxymethyl theophylline.
Claim 9
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(N,N-diethylamidosuccinyloxymethyl)theophylline.
Claim 10
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(N,N-dimethylglycyloxymethyl)theophylline.
Claim 11
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Ethoxymethyl-theophylline.
Claim 12
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Butyloxymethyl-theophylline.
Claim 13
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Benzyloxymethyl-theophylline.
Claim 14
Dependent Claim 11 words
The method of claim 1, wherein said compound is: 7-(1-Pyridyl)methyl-theophylline chloride.
Claim 15
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(N,N-dimethylaminoethyoxyl)methyl-theophylline.
Claim 16
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Acetyloxymethyl-theophylline.
Claim 17
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Butanoyloxymethyl-theophylline.
Claim 18
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Ethoxycarbonyloxymethyl-theophylline.
Claim 19
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Benzyloxycarbonyloxymethyl-theophylline.
Claim 20
Dependent Claim 12 words
The method of claim 1, wherein said compound is: 7-(2', 2', 2',-Trichloroethyloxycarbonyloxymethyl)-theophylline.
Claim 21
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(N,N-Dimethylglycyloxymethyl)-theophylline.
Claim 22
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(1-Piperidylacetyloxymethyl)-theophylline.
Claim 23
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-p-Toluyloxymethyl-theophylline.
Claim 24
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Phenylacetyloxymethyl-theophylline.
Claim 25
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Picolinoyloxymethyl-theophylline.
Claim 26
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-N-Formylglycyloxymethyl-theophylline.
Claim 27
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Glycyloxymethyl-theophylline.
Claim 28
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Cinnamoyloxymethyl-theophylline.
Claim 29
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Methylsuccinyloxymethyl-theophylline.
Claim 30
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(N,N-Dimethylsuccinamyloxymethyl)-theophylline.
Claim 31
Dependent Claim 11 words
The method of claim 1, wherein said compound is: 7-(N,N,N-Trimethylglycyloxymethyl)-theophylline chloride.
Claim 32
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(α-Ethoxyethyl)-theophylline.
Claim 33
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(α-Benzyloxyethyl)-theophylline.
Claim 34
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(α-Acetyloxyethyl)-theophylline.
Claim 35
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(α-Butanoyloxyethyl)-theophylline.
Claim 36
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(α-Pivalyloxyethyl)-theophylline.
Claim 37
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(α-Ethoxycarbonyloxyethyl)-theophylline.
Claim 38
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-[α-(N,N-Dimethylglycyloxy)ethyl]-theophylline.
Claim 39
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(α-Benzoyloxyethyl)-theophylline.
Claim 40
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-[α-(N,N-Dimethylsuccinamyloxy)ethyl]-theophylline.
Claim 41
Dependent Claim 11 words
The method of claim 1, wherein said compound is: 7-[α-(N,N,N-Trimethylglycyloxy)ethyl]-theophylline chloride.
Claim 42
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(α-Benzyloxybenzyl)-theophylline.
Claim 43
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(α-Acetyloxybenzyl)-theophylline.
Claim 44
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(α-Butanoyloxybenzyl)-theophylline.
Claim 45
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(α-Ethoxycarbonyloxybenzyl)-theophylline.
Claim 46
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-[α-(N,N-Dimethylglycyloxy)benzyl]-theophylline.
Claim 47
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-[α-(N-Formylglycyloxy)benzyl]-theophylline.
Claim 48
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(α-Methylsuccinyloxybenzyl)-theophylline.
Claim 49
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-[α-(N,N,-Dimethylsuccinamyloxy)benzyl]-theophylline.
Claim 50
Dependent Claim 11 words
The method of claim 1, wherein said compound is: 7-[α-(N,N,N-Trimethylglycyloxy)benzyl]-theophylline chloride.
Claim 51
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Ethoxymethyl-1-methyl-3-isobutylxanthine.
Claim 52
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Butyloxymethyl-1-methyl-3-isobutylxanthine.
Claim 53
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Benzyloxymethyl-1-methyl-3-isobutylxanthine.
Claim 54
Dependent Claim 11 words
The method of claim 1, wherein said compound is: 7-(1-Pyridyl)methyl-1-methyl-3-isobutylxanthine chloride.
Claim 55
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(N,N-dimethylaminoethyloxy)methyl-1-methyl-3-isobutylxanthine.
Claim 56
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Acetyloxymethyl-1-methyl-3-isobutylxanthine.
Claim 57
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Butanoyloxymethyl-1-methyl-3-isobutylxanthine.
Claim 58
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Pivalyloxymethyl-1-methyl-3-isobutylxanthine.
Claim 59
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Hexanoyloxymethyl-1-methyl-3-isobutylxanthine.
Claim 60
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Ethoxycarbonyloxymethyl-1-methyl--3-isobutylxanthine.
Claim 61
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Benzyloxycarbonyloxymethyl-1-methyl-3-isobutylxanthine.
Claim 62
Dependent Claim 12 words
The method of claim 1, wherein said compound is: 7-(2', 2', 2'-Trichloroethyloxycarbonyloxymethyl)-1-methyl-3-isobutylxanthine.
Claim 63
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(N,N,-Dimethylglycyloxymethyl)-1-methyl-3-isobutylxanthine.
Claim 64
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(1-Piperidylacetyloxymethyl)-1-methyl-3-isobutylxanthine.
Claim 65
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-p-Toluyloxymethyl-1-methyl-3-isobutylxanthine.
Claim 66
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Phenylacetyloxymethyl-1-methyl-3-isobutylxanthine.
Claim 67
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Picolinoyloxymethyl-1-methyl-3-isobutylxanthine.
Claim 68
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-N-Formylglycyloxymethyl-1-methyl-3-isobutylxanthine.
Claim 69
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Glycyloxymethyl-1-methyl-3-isobutylxanthine.
Claim 70
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Cinnamoyloxymethyl-1-methyl-3-isobutylxanthine.
Claim 71
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Methylsuccinyloxymethyl-1-methyl-3-isobutylxanthine.
Claim 72
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(N,N-Dimethylsuccinamyloxymethyl)-1-methyl-3-isobutylxanthine.
Claim 73
Dependent Claim 11 words
The method of claim 1, wherein said compound is: 7-(N,N,N-Trimethylglycyloxymethyl)-1-methyl-3-isobutylxanthine chloride.
Claim 74
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(α-Ethoxyethyl)-1-methyl-3-isobutylxanthine.
Claim 75
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(α-Benzyloxyethyl)-1-methyl-3-isobutylxanthine.
Claim 76
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(α-Acetyloxyethyl)-1-methyl-3-isobutylxanthine.
Claim 77
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(α-Butanoyloxyethyl)-1-methyl-3-isobutylxanthine.
Claim 78
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(α-Pivalyloxyethyl)-1-methyl-3-isobutylxanthine.
Claim 79
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(α-Ethoxycarbonyloxyethyl)-1-methyl-3-isobutylxanthine.
Claim 80
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-[α-(N,N-Dimethylglycyloxy)ethyl]-1-methyl-3-isobutylxanthine.
Claim 81
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(α-Benzoyloxyethyl)-1-methyl-3-isobutylxanthine.
Claim 82
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-[α-(N,N-Dimethylsuccinamyloxy)ethyl-1-methyl-3-isobutylxanthine.
Claim 83
Dependent Claim 11 words
The method of claim 1, wherein said compound is: 7-[α-(N,N,N-Trimethylglycyloxy)ethyl]-1-methyl-3-isobutylxanthine chloride.
Claim 84
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(α-Benzyloxybenzyl)-1-methyl-3-isobutylxanthine.
Claim 85
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(α-Acetyloxybenzyl)-1-methyl-3-isobutylxanthine.
Claim 86
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(α-Butanoyloxybenzyl)-1-methyl-3-isobutylxanthine.
Claim 87
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(α-Ethoxycarbonyloxybenzyl)-1-methyl-3-isobutylxanthine.
Claim 88
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-[α-(N,N-Dimethylglycyloxy)benzyl]-1-methyl-3-isobutylxanthine.
Claim 89
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-[α-(N-Formylglycyloxy)benzyl]-1-methyl-3-isobutylxanthine.
Claim 90
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(α-Methylsuccinyloxybenzyl)-1-methyl-3-isobutylxanthine.
Claim 91
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-[α-(N,N-Dimethylsuccinamyloxy)benzyl]-1-methyl-3-isobutylxanthine.
Claim 92
Dependent Claim 11 words
The method of claim 1, wherein said compound is: 7-[α-(N,N,N-Trimethylglycyloxy)benzyl]-1-methyl-3-isobutylxanthine chloride.
Claim 93
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Acetylthiomethyl-theophylline.
Claim 94
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Propionylthiomethyl-theophylline.
Claim 95
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(N,N-Dimethylglycylthiomethyl)-theophylline.
Claim 96
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-p-Toluylthiomethyl-theophylline.
Claim 97
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-Cinnamoylthiomethyl-theophylline.
Claim 98
Dependent Claim 10 words
The method of claim 1, wherein said compound is: 7-(N,N-Diethylsuccinamylthiomethyl)-theophylline.
Claim 99
Dependent Claim 17 words
The method of claim 1, wherein said compound is combined with a pharmaceutically acceptable topical carrier material.
Claim 100
Dependent Claim 14 words
The method of claim 98, wherein said pharmaceutically acceptable topical carrier material is triacetin.

References Cited (Backward Citations)

FR1265879A Cited
DE1226587B Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-12-05 1981-06-06 1981-12-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-12-05 1985-06-06 1985-12-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-12-05 1989-06-06 1989-12-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag